← Back to Search

Stent Graft

Valiant Evo Thoracic Stent Graft System for Thoracic Aortic Aneurysm

N/A
Waitlist Available
Led By Fabio Verzini, Prof.
Research Sponsored by Medtronic Cardiovascular
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 month
Awards & highlights

Study Summary

This trial is testing a new device to treat people with a specific type of aortic aneurysm. The goal is to show that the device is safe and effective.

Eligible Conditions
  • Thoracic Aortic Aneurysm

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite Safety and Effectiveness Endpoint That is Based on the Percentage of Subjects Who Experienced (a) Access and/or Deployment Failures; and/or (b) Major Device Effect (MDE) Within 30 Days Post Index Procedure
Secondary outcome measures
Safety and Effectiveness Outcome

Trial Design

1Treatment groups
Experimental Treatment
Group I: Endovascular repairExperimental Treatment1 Intervention
Valiant Evo Thoracic Stent Graft System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Valiant Evo Thoracic Stent Graft System
2016
N/A
~200

Find a Location

Who is running the clinical trial?

Medtronic CardiovascularLead Sponsor
75 Previous Clinical Trials
36,232 Total Patients Enrolled
Fabio Verzini, Prof.Principal InvestigatorA.O.U. Citta della Salute e della Scienza

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can patients still participate in the ongoing clinical trial?

"The information posted on clinicaltrials.gov indicates that this trial is no longer recruiting patients, despite being initially published in April of 2016 and last updated November 4th 2022. Thankfully there are 152 other medical studies actively seeking participants right now."

Answered by AI
Recent research and studies
Journal of Vascular SurgeryJournal
Pivotal Results for the Valiant Navion Stent Graft System in the Valiant EVO Global Clinical Trial
Azizzadeh, Ali, Nimesh Desai, Frank R. Arko III, Jean M. Panneton, Fabien Thaveau, Paul Hayes, Francois Dagenais, Lanyu Lei, and Fabio Verzini. 2019. “Pivotal Results for the Valiant Navion Stent Graft System in the Valiant EVO Global Clinical Trial”. Journal of Vascular Surgery. Elsevier BV. doi:10.1016/j.jvs.2019.01.067.
Journal of Vascular SurgeryJournal
A Preliminary Analysis of Late Structural Failures of the Navion Stent Graft in the Treatment of Descending Thoracic Aortic Aneurysms
Verzini, Fabio, Enrico Cieri, Andrea Kahlberg, Yaron Sternbach, Robin Heijmen, Kenneth Ouriel, Sam Robaina, and Ali Azizzadeh. 2021. “A Preliminary Analysis of Late Structural Failures of the Navion Stent Graft in the Treatment of Descending Thoracic Aortic Aneurysms”. Journal of Vascular Surgery. Elsevier BV. doi:10.1016/j.jvs.2021.04.018.
clinicaltrials.govStudy
Valiant Evo International Clinical Trial
2016. "Valiant Evo International Clinical Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02625324.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top